The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 26.21

Cancer of the Thyroid (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2016
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to <5 5 to <10 10 to <15 15 to <20 20 to <24 0 to <24b >=24d
All Races Both Sexes 229,536 178,307 117,358 75,019 44,352 644,572 177,670 822,242
Males 55,079 39,028 24,894 15,512 9,579 144,092 41,510 185,603
Females 174,457 139,279 92,464 59,507 34,772 500,479 136,160 636,639
White Both Sexes 194,120 153,635 102,911 66,508 39,197 556,372 159,207 724,029
Males 48,082 34,690 22,384 14,132 8,661 127,948 35,724 165,484
Females 146,039 118,945 80,527 52,377 30,537 428,424 123,483 558,545
Black Both Sexes 16,940 12,042 7,223 3,846 2,299 42,351 9,745 52,096
Males 3,033 1,940 1,223 595 424 7,216 1,457 8,673
Females 13,907 10,102 6,000 3,251 1,876 35,135 8,288 43,423
Asian/
Pacific
Islander
Both Sexes 12,778 8,972 5,547 3,447 2,035 32,779 + +
Males 2,759 1,623 921 590 322 6,214 + +
Females 10,019 7,349 4,626 2,857 1,713 26,565 + +
Hispanic Both Sexes 27,552 18,698 11,559 7,140 4,052 69,000 + +
Males 5,118 2,980 1,911 1,134 616 11,759 + +
Females 22,434 15,718 9,648 6,006 3,436 57,241 + +

Estimated prevalence percent a on January 1, 2016, of the SEER population diagnosed in the previous 24 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.2000 0.0002 0.0067 0.0490 0.1582 0.2959 0.3791 0.4108 0.4157 0.2932 0.1832
Males 0.0908 0.0002 0.0027 0.0168 0.0504 0.1124 0.1612 0.2225 0.2658 0.2103 0.0842
Females 0.3060 0.0002 0.0109 0.0827 0.2666 0.4765 0.5873 0.5814 0.5406 0.3442 0.2773
White Both Sexes 0.2206 0.0002 0.0075 0.0560 0.1764 0.3217 0.4085 0.4282 0.4282 0.3006 0.1965
Males 0.1024 0.0003 0.0030 0.0195 0.0559 0.1233 0.1759 0.2369 0.2790 0.2179 0.0908
Females 0.3368 0.0002 0.0123 0.0944 0.3009 0.5223 0.6355 0.6056 0.5552 0.3523 0.2996
Black Both Sexes 0.0939 - 0.0020 0.0150 0.0630 0.1529 0.1988 0.2628 0.2903 0.1967 0.1003
Males 0.0334 - 0.0010 0.0033 0.0170 0.0464 0.0725 0.1103 0.1455 0.1325 0.0394
Females 0.1497 - 0.0030 0.0268 0.1052 0.2474 0.3088 0.3845 0.3911 0.2284 0.1511
Asian/
Pacific
Islander
Both Sexes 0.1610 - 0.0060 0.0417 0.1281 0.2505 0.3186 0.3812 0.3769 0.2802 0.1595
Males 0.0637 - 0.0027 0.0132 0.0425 0.0970 0.1229 0.1725 0.2037 0.1631 0.0673
Females 0.2505 - 0.0095 0.0703 0.2054 0.3865 0.4880 0.5498 0.5161 0.3556 0.2384
Hispanic Both Sexes 0.1208 0.0001 0.0072 0.0410 0.1255 0.2228 0.3018 0.3534 0.3793 0.2723 0.1508
Males 0.0407 0.0001 0.0033 0.0117 0.0307 0.0691 0.1011 0.1515 0.1986 0.1503 0.0566
Females 0.2026 - 0.0112 0.0730 0.2280 0.3810 0.4995 0.5320 0.5178 0.3477 0.2413

Footnotes:

a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2016 US population estimates based on the average of 2015 and 2016 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years.

b Maximum limited-duration prevalence is 24 years for 1992-2016 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing 0 to <24 and >=24.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.